Dr. Aleksei Volkov, MD, PhD
Longevity & Peptide Therapy ReviewerDr. Volkov trained at Sechenov University and completed his PhD under the supervision of Prof. Khavinson at the Institute of Bioregulation and Gerontology in St. Petersburg — the research institute responsible for developing epithalon, thymalin, and the foundational peptide bioregulator library. He has 12 years of clinical experience in longevity medicine and peptide therapy protocols, and brings direct knowledge of the Russian clinical literature that forms the evidence base for many bioregulator compounds. He joined BiohackingHub as Longevity & Peptide Therapy Reviewer in 2025.
Credentials & Qualifications
- MD — First Moscow State Medical University (Sechenov University)
- PhD Gerontology — Institute of Bioregulation and Gerontology, St. Petersburg
- Clinical Fellowship: Preventive Medicine & Longevity, European Longevity Institute
- Certified Peptide Therapy Practitioner (ACAM)
Selected Publications
Epithalon-mediated telomerase activation: 15-year follow-up of peptide bioregulator cohorts
Bulletin of Experimental Biology and Medicine·2024
Recent Reviewed Content
Autophagy Optimization: Spermidine and the Science of Cellular Cleaning
Mar 2, 2026 · Oxford 2b
The Epigenetic Clock: How Peptides and Interventions Change DNA Methylation Age
Mar 7, 2026 · Oxford 2b
Epitalon vs. Epithalamin: Synthetic Peptide vs. Natural Extract
Mar 7, 2026 · Oxford 4
Epitalon (AEDG) 2026: The Definitive Guide to Telomerase Activation
Mar 8, 2026 · Oxford 3
Ipamorelin & CJC-1295: The Safe Stack for Growth Hormone Optimisation
Mar 9, 2026 · Oxford 4
Methylene Blue + Nootropics: Mitochondrial Biohacking Deep Dive
Mar 11, 2026 · Oxford 3
Specialisations
Member since
March 2025